nodes	percent_of_prediction	percent_of_DWPC	metapath
Propofol—UGT1A6—Mycophenolic acid—psoriasis	0.155	0.199	CbGbCtD
Propofol—UGT1A8—Mycophenolate mofetil—psoriasis	0.1	0.129	CbGbCtD
Propofol—UGT1A6—Mycophenolate mofetil—psoriasis	0.0868	0.111	CbGbCtD
Propofol—UGT1A9—Mycophenolic acid—psoriasis	0.0453	0.058	CbGbCtD
Propofol—UGT1A1—Mycophenolic acid—psoriasis	0.0371	0.0475	CbGbCtD
Propofol—CYP1A1—Clobetasol propionate—psoriasis	0.0349	0.0446	CbGbCtD
Propofol—UGT1A9—Mycophenolate mofetil—psoriasis	0.0253	0.0324	CbGbCtD
Propofol—CYP2A6—Methoxsalen—psoriasis	0.0214	0.0274	CbGbCtD
Propofol—UGT1A1—Mycophenolate mofetil—psoriasis	0.0207	0.0265	CbGbCtD
Propofol—CYP1A1—Methoxsalen—psoriasis	0.0183	0.0234	CbGbCtD
Propofol—ALB—Acitretin—psoriasis	0.0168	0.0215	CbGbCtD
Propofol—CYP2C8—Tazarotene—psoriasis	0.0164	0.021	CbGbCtD
Propofol—CYP1A2—Clobetasol propionate—psoriasis	0.0156	0.0199	CbGbCtD
Propofol—CYP1A1—Cholecalciferol—psoriasis	0.0121	0.0155	CbGbCtD
Propofol—CYP1B1—Dexamethasone—psoriasis	0.012	0.0153	CbGbCtD
Propofol—CYP2A6—Prednisolone—psoriasis	0.0104	0.0133	CbGbCtD
Propofol—CYP2B6—Cholecalciferol—psoriasis	0.00924	0.0118	CbGbCtD
Propofol—CYP1A2—Methoxsalen—psoriasis	0.00818	0.0105	CbGbCtD
Propofol—ALB—Mycophenolate mofetil—psoriasis	0.00785	0.0101	CbGbCtD
Propofol—CYP2D6—Hydroxyurea—psoriasis	0.00737	0.00944	CbGbCtD
Propofol—CYP2C8—Cholecalciferol—psoriasis	0.007	0.00896	CbGbCtD
Propofol—ALB—Prednisone—psoriasis	0.00628	0.00804	CbGbCtD
Propofol—CYP2A6—Dexamethasone—psoriasis	0.00614	0.00787	CbGbCtD
Propofol—CYP2C8—Mycophenolate mofetil—psoriasis	0.00607	0.00777	CbGbCtD
Propofol—CYP2C19—Cholecalciferol—psoriasis	0.00587	0.00752	CbGbCtD
Propofol—CYP3A4—Calcitriol—psoriasis	0.00551	0.00706	CbGbCtD
Propofol—CYP1A1—Dexamethasone—psoriasis	0.00525	0.00672	CbGbCtD
Propofol—CYP2C9—Cholecalciferol—psoriasis	0.00488	0.00625	CbGbCtD
Propofol—CYP2C8—Hydrocortisone—psoriasis	0.00487	0.00624	CbGbCtD
Propofol—CYP2C8—Cyclosporine—psoriasis	0.0046	0.00589	CbGbCtD
Propofol—CYP2D6—Cholecalciferol—psoriasis	0.00446	0.00572	CbGbCtD
Propofol—CYP3A4—Methoxsalen—psoriasis	0.00429	0.00549	CbGbCtD
Propofol—CYP2C19—Prednisone—psoriasis	0.00407	0.00521	CbGbCtD
Propofol—CYP2E1—Dexamethasone—psoriasis	0.00405	0.00519	CbGbCtD
Propofol—CYP2B6—Dexamethasone—psoriasis	0.004	0.00512	CbGbCtD
Propofol—CYP2C19—Cyclosporine—psoriasis	0.00386	0.00494	CbGbCtD
Propofol—CYP2C9—Cyclosporine—psoriasis	0.00321	0.00411	CbGbCtD
Propofol—ALB—Methotrexate—psoriasis	0.00315	0.00403	CbGbCtD
Propofol—CYP2C8—Dexamethasone—psoriasis	0.00303	0.00388	CbGbCtD
Propofol—CYP2D6—Cyclosporine—psoriasis	0.00293	0.00376	CbGbCtD
Propofol—CYP3A4—Cholecalciferol—psoriasis	0.00284	0.00364	CbGbCtD
Propofol—CYP2C19—Dexamethasone—psoriasis	0.00254	0.00325	CbGbCtD
Propofol—CYP3A4—Mycophenolate mofetil—psoriasis	0.00246	0.00315	CbGbCtD
Propofol—CYP3A4—Triamcinolone—psoriasis	0.00246	0.00315	CbGbCtD
Propofol—CYP2C9—Dexamethasone—psoriasis	0.00211	0.00271	CbGbCtD
Propofol—CYP3A4—Betamethasone—psoriasis	0.00211	0.0027	CbGbCtD
Propofol—CYP3A4—Prednisolone—psoriasis	0.00208	0.00267	CbGbCtD
Propofol—CYP3A4—Hydrocortisone—psoriasis	0.00198	0.00253	CbGbCtD
Propofol—CYP3A4—Prednisone—psoriasis	0.00197	0.00252	CbGbCtD
Propofol—CYP2D6—Dexamethasone—psoriasis	0.00193	0.00247	CbGbCtD
Propofol—CYP3A4—Cyclosporine—psoriasis	0.00187	0.00239	CbGbCtD
Propofol—CYP3A4—Dexamethasone—psoriasis	0.00123	0.00157	CbGbCtD
Propofol—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL12B—psoriasis	9.13e-05	0.0018	CbGpPWpGaD
Propofol—ALB—Hemostasis—SERPINB8—psoriasis	9.02e-05	0.00178	CbGpPWpGaD
Propofol—CYP1A1—PPARA activates gene expression—CARM1—psoriasis	8.98e-05	0.00177	CbGpPWpGaD
Propofol—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—CARM1—psoriasis	8.79e-05	0.00174	CbGpPWpGaD
Propofol—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—psoriasis	8.74e-05	0.00173	CbGpPWpGaD
Propofol—CYP1B1—Aryl Hydrocarbon Receptor Pathway—JUN—psoriasis	8.64e-05	0.00171	CbGpPWpGaD
Propofol—UGT1A6—Metabolism—CYP2S1—psoriasis	8.63e-05	0.00171	CbGpPWpGaD
Propofol—ALB—Binding and Uptake of Ligands by Scavenger Receptors—APOE—psoriasis	8.61e-05	0.0017	CbGpPWpGaD
Propofol—CYP1B1—Aryl Hydrocarbon Receptor—NFKB1—psoriasis	8.32e-05	0.00164	CbGpPWpGaD
Propofol—CYP1A2—Biological oxidations—CYP2S1—psoriasis	8.2e-05	0.00162	CbGpPWpGaD
Propofol—Hypotension—Mycophenolate mofetil—psoriasis	8.12e-05	0.000482	CcSEcCtD
Propofol—Musculoskeletal discomfort—Cyclosporine—psoriasis	8.12e-05	0.000482	CcSEcCtD
Propofol—Oedema—Prednisolone—psoriasis	8.11e-05	0.000481	CcSEcCtD
Propofol—Anaphylactic shock—Prednisolone—psoriasis	8.11e-05	0.000481	CcSEcCtD
Propofol—CYP1A2—Metapathway biotransformation—CYP2S1—psoriasis	8.08e-05	0.0016	CbGpPWpGaD
Propofol—CYP1A2—Estrogen Receptor Pathway—STAT3—psoriasis	8.07e-05	0.00159	CbGpPWpGaD
Propofol—Insomnia—Cyclosporine—psoriasis	8.06e-05	0.000478	CcSEcCtD
Propofol—Loss of consciousness—Triamcinolone—psoriasis	8.03e-05	0.000476	CcSEcCtD
Propofol—Paraesthesia—Cyclosporine—psoriasis	8e-05	0.000475	CcSEcCtD
Propofol—Shock—Prednisolone—psoriasis	7.97e-05	0.000473	CcSEcCtD
Propofol—Cough—Triamcinolone—psoriasis	7.97e-05	0.000473	CcSEcCtD
Propofol—CYP1A2—Melatonin metabolism and effects—APOE—psoriasis	7.95e-05	0.00157	CbGpPWpGaD
Propofol—Dyspnoea—Cyclosporine—psoriasis	7.94e-05	0.000471	CcSEcCtD
Propofol—Somnolence—Cyclosporine—psoriasis	7.92e-05	0.00047	CcSEcCtD
Propofol—Musculoskeletal discomfort—Mycophenolate mofetil—psoriasis	7.92e-05	0.00047	CcSEcCtD
Propofol—Anaphylactic shock—Hydrocortisone—psoriasis	7.92e-05	0.00047	CcSEcCtD
Propofol—Oedema—Hydrocortisone—psoriasis	7.92e-05	0.00047	CcSEcCtD
Propofol—Convulsion—Triamcinolone—psoriasis	7.91e-05	0.00047	CcSEcCtD
Propofol—Tachycardia—Prednisolone—psoriasis	7.91e-05	0.000469	CcSEcCtD
Propofol—Asthenia—Mycophenolic acid—psoriasis	7.9e-05	0.000469	CcSEcCtD
Propofol—Hypertension—Triamcinolone—psoriasis	7.89e-05	0.000468	CcSEcCtD
Propofol—Insomnia—Mycophenolate mofetil—psoriasis	7.86e-05	0.000466	CcSEcCtD
Propofol—Hyperhidrosis—Prednisolone—psoriasis	7.84e-05	0.000465	CcSEcCtD
Propofol—Nausea—Hydroxyurea—psoriasis	7.81e-05	0.000463	CcSEcCtD
Propofol—Paraesthesia—Mycophenolate mofetil—psoriasis	7.8e-05	0.000463	CcSEcCtD
Propofol—Pruritus—Mycophenolic acid—psoriasis	7.79e-05	0.000462	CcSEcCtD
Propofol—Shock—Hydrocortisone—psoriasis	7.79e-05	0.000462	CcSEcCtD
Propofol—Myalgia—Triamcinolone—psoriasis	7.78e-05	0.000461	CcSEcCtD
Propofol—Dyspnoea—Mycophenolate mofetil—psoriasis	7.75e-05	0.00046	CcSEcCtD
Propofol—Tachycardia—Hydrocortisone—psoriasis	7.73e-05	0.000458	CcSEcCtD
Propofol—Somnolence—Mycophenolate mofetil—psoriasis	7.73e-05	0.000458	CcSEcCtD
Propofol—Depression—Methotrexate—psoriasis	7.7e-05	0.000457	CcSEcCtD
Propofol—Flushing—Prednisone—psoriasis	7.69e-05	0.000457	CcSEcCtD
Propofol—Fatigue—Cyclosporine—psoriasis	7.68e-05	0.000456	CcSEcCtD
Propofol—Hyperhidrosis—Hydrocortisone—psoriasis	7.65e-05	0.000454	CcSEcCtD
Propofol—Pain—Cyclosporine—psoriasis	7.62e-05	0.000452	CcSEcCtD
Propofol—Dry mouth—Triamcinolone—psoriasis	7.6e-05	0.000451	CcSEcCtD
Propofol—Renal failure—Methotrexate—psoriasis	7.59e-05	0.00045	CcSEcCtD
Propofol—ALB—Folate Metabolism—CAT—psoriasis	7.57e-05	0.0015	CbGpPWpGaD
Propofol—Angioedema—Betamethasone—psoriasis	7.57e-05	0.000449	CcSEcCtD
Propofol—Angioedema—Dexamethasone—psoriasis	7.57e-05	0.000449	CcSEcCtD
Propofol—CYP1B1—Aryl Hydrocarbon Receptor—VEGFA—psoriasis	7.55e-05	0.00149	CbGpPWpGaD
Propofol—Diarrhoea—Mycophenolic acid—psoriasis	7.53e-05	0.000447	CcSEcCtD
Propofol—Anaphylactic shock—Triamcinolone—psoriasis	7.45e-05	0.000442	CcSEcCtD
Propofol—Oedema—Triamcinolone—psoriasis	7.45e-05	0.000442	CcSEcCtD
Propofol—Syncope—Dexamethasone—psoriasis	7.43e-05	0.000441	CcSEcCtD
Propofol—Syncope—Betamethasone—psoriasis	7.43e-05	0.000441	CcSEcCtD
Propofol—Pain—Mycophenolate mofetil—psoriasis	7.43e-05	0.000441	CcSEcCtD
Propofol—CYP1A1—Melatonin metabolism and effects—NFKB1—psoriasis	7.41e-05	0.00146	CbGpPWpGaD
Propofol—Arrhythmia—Prednisone—psoriasis	7.41e-05	0.000439	CcSEcCtD
Propofol—Hypotension—Hydrocortisone—psoriasis	7.4e-05	0.000439	CcSEcCtD
Propofol—ALB—Vitamin B12 Metabolism—CRP—psoriasis	7.39e-05	0.00146	CbGpPWpGaD
Propofol—ALB—Lipid and lipoprotein metabolism—APOE—psoriasis	7.35e-05	0.00145	CbGpPWpGaD
Propofol—Feeling abnormal—Cyclosporine—psoriasis	7.34e-05	0.000436	CcSEcCtD
Propofol—Shock—Triamcinolone—psoriasis	7.33e-05	0.000435	CcSEcCtD
Propofol—Insomnia—Prednisolone—psoriasis	7.33e-05	0.000435	CcSEcCtD
Propofol—Loss of consciousness—Dexamethasone—psoriasis	7.28e-05	0.000432	CcSEcCtD
Propofol—Loss of consciousness—Betamethasone—psoriasis	7.28e-05	0.000432	CcSEcCtD
Propofol—Dizziness—Mycophenolic acid—psoriasis	7.28e-05	0.000432	CcSEcCtD
Propofol—Paraesthesia—Prednisolone—psoriasis	7.28e-05	0.000432	CcSEcCtD
Propofol—Tachycardia—Triamcinolone—psoriasis	7.28e-05	0.000432	CcSEcCtD
Propofol—ALB—Vitamin B12 Metabolism—APOE—psoriasis	7.23e-05	0.00143	CbGpPWpGaD
Propofol—Erythema—Prednisone—psoriasis	7.22e-05	0.000428	CcSEcCtD
Propofol—CYP1A1—Oxidative Stress—NFKB1—psoriasis	7.21e-05	0.00143	CbGpPWpGaD
Propofol—Musculoskeletal discomfort—Hydrocortisone—psoriasis	7.21e-05	0.000428	CcSEcCtD
Propofol—Hyperhidrosis—Triamcinolone—psoriasis	7.21e-05	0.000428	CcSEcCtD
Propofol—Convulsion—Dexamethasone—psoriasis	7.18e-05	0.000426	CcSEcCtD
Propofol—Convulsion—Betamethasone—psoriasis	7.18e-05	0.000426	CcSEcCtD
Propofol—Feeling abnormal—Mycophenolate mofetil—psoriasis	7.16e-05	0.000425	CcSEcCtD
Propofol—Insomnia—Hydrocortisone—psoriasis	7.16e-05	0.000425	CcSEcCtD
Propofol—Hypertension—Betamethasone—psoriasis	7.16e-05	0.000425	CcSEcCtD
Propofol—Hypertension—Dexamethasone—psoriasis	7.16e-05	0.000425	CcSEcCtD
Propofol—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	7.13e-05	0.00141	CbGpPWpGaD
Propofol—Paraesthesia—Hydrocortisone—psoriasis	7.11e-05	0.000422	CcSEcCtD
Propofol—Urticaria—Cyclosporine—psoriasis	7.08e-05	0.00042	CcSEcCtD
Propofol—CYP1A2—Tryptophan metabolism—CAT—psoriasis	7.07e-05	0.0014	CbGpPWpGaD
Propofol—Myalgia—Betamethasone—psoriasis	7.06e-05	0.000419	CcSEcCtD
Propofol—Myalgia—Dexamethasone—psoriasis	7.06e-05	0.000419	CcSEcCtD
Propofol—Abdominal pain—Cyclosporine—psoriasis	7.04e-05	0.000418	CcSEcCtD
Propofol—Body temperature increased—Cyclosporine—psoriasis	7.04e-05	0.000418	CcSEcCtD
Propofol—Anxiety—Betamethasone—psoriasis	7.03e-05	0.000417	CcSEcCtD
Propofol—Anxiety—Dexamethasone—psoriasis	7.03e-05	0.000417	CcSEcCtD
Propofol—Vomiting—Mycophenolic acid—psoriasis	7e-05	0.000415	CcSEcCtD
Propofol—Haemoglobin—Methotrexate—psoriasis	6.96e-05	0.000413	CcSEcCtD
Propofol—ALB—Folate Metabolism—IL4—psoriasis	6.96e-05	0.00137	CbGpPWpGaD
Propofol—Rash—Mycophenolic acid—psoriasis	6.94e-05	0.000412	CcSEcCtD
Propofol—UGT1A1—Aryl Hydrocarbon Receptor Pathway—TNF—psoriasis	6.94e-05	0.00137	CbGpPWpGaD
Propofol—UGT1A9—Aryl Hydrocarbon Receptor Pathway—TNF—psoriasis	6.94e-05	0.00137	CbGpPWpGaD
Propofol—Dermatitis—Mycophenolic acid—psoriasis	6.94e-05	0.000412	CcSEcCtD
Propofol—Pain—Prednisolone—psoriasis	6.93e-05	0.000411	CcSEcCtD
Propofol—Haemorrhage—Methotrexate—psoriasis	6.93e-05	0.000411	CcSEcCtD
Propofol—Urticaria—Mycophenolate mofetil—psoriasis	6.9e-05	0.00041	CcSEcCtD
Propofol—Headache—Mycophenolic acid—psoriasis	6.9e-05	0.000409	CcSEcCtD
Propofol—Pharyngitis—Methotrexate—psoriasis	6.88e-05	0.000408	CcSEcCtD
Propofol—Abdominal pain—Mycophenolate mofetil—psoriasis	6.87e-05	0.000408	CcSEcCtD
Propofol—Body temperature increased—Mycophenolate mofetil—psoriasis	6.87e-05	0.000408	CcSEcCtD
Propofol—Fatigue—Hydrocortisone—psoriasis	6.83e-05	0.000405	CcSEcCtD
Propofol—ALB—Vitamin B12 Metabolism—ICAM1—psoriasis	6.79e-05	0.00134	CbGpPWpGaD
Propofol—Musculoskeletal discomfort—Triamcinolone—psoriasis	6.79e-05	0.000403	CcSEcCtD
Propofol—Pain—Hydrocortisone—psoriasis	6.77e-05	0.000402	CcSEcCtD
Propofol—Oedema—Dexamethasone—psoriasis	6.76e-05	0.000401	CcSEcCtD
Propofol—Anaphylactic shock—Dexamethasone—psoriasis	6.76e-05	0.000401	CcSEcCtD
Propofol—Oedema—Betamethasone—psoriasis	6.76e-05	0.000401	CcSEcCtD
Propofol—Anaphylactic shock—Betamethasone—psoriasis	6.76e-05	0.000401	CcSEcCtD
Propofol—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—psoriasis	6.75e-05	0.00133	CbGpPWpGaD
Propofol—Insomnia—Triamcinolone—psoriasis	6.74e-05	0.0004	CcSEcCtD
Propofol—Paraesthesia—Triamcinolone—psoriasis	6.69e-05	0.000397	CcSEcCtD
Propofol—Feeling abnormal—Prednisolone—psoriasis	6.68e-05	0.000396	CcSEcCtD
Propofol—Visual impairment—Methotrexate—psoriasis	6.68e-05	0.000396	CcSEcCtD
Propofol—Shock—Dexamethasone—psoriasis	6.65e-05	0.000395	CcSEcCtD
Propofol—Shock—Betamethasone—psoriasis	6.65e-05	0.000395	CcSEcCtD
Propofol—Dyspnoea—Triamcinolone—psoriasis	6.65e-05	0.000394	CcSEcCtD
Propofol—Agitation—Prednisone—psoriasis	6.63e-05	0.000394	CcSEcCtD
Propofol—Tachycardia—Betamethasone—psoriasis	6.6e-05	0.000392	CcSEcCtD
Propofol—Tachycardia—Dexamethasone—psoriasis	6.6e-05	0.000392	CcSEcCtD
Propofol—Angioedema—Prednisone—psoriasis	6.59e-05	0.000391	CcSEcCtD
Propofol—Nausea—Mycophenolic acid—psoriasis	6.54e-05	0.000388	CcSEcCtD
Propofol—Hyperhidrosis—Betamethasone—psoriasis	6.54e-05	0.000388	CcSEcCtD
Propofol—Hyperhidrosis—Dexamethasone—psoriasis	6.54e-05	0.000388	CcSEcCtD
Propofol—Feeling abnormal—Hydrocortisone—psoriasis	6.52e-05	0.000387	CcSEcCtD
Propofol—UGT1A9—PPARA activates gene expression—PPARG—psoriasis	6.51e-05	0.00129	CbGpPWpGaD
Propofol—CYP1B1—Aryl Hydrocarbon Receptor Pathway—TNF—psoriasis	6.47e-05	0.00128	CbGpPWpGaD
Propofol—CYP1B1—Aryl Hydrocarbon Receptor—TNF—psoriasis	6.47e-05	0.00128	CbGpPWpGaD
Propofol—Syncope—Prednisone—psoriasis	6.47e-05	0.000384	CcSEcCtD
Propofol—Tinnitus—Methotrexate—psoriasis	6.46e-05	0.000383	CcSEcCtD
Propofol—Urticaria—Prednisolone—psoriasis	6.44e-05	0.000382	CcSEcCtD
Propofol—Fatigue—Triamcinolone—psoriasis	6.43e-05	0.000381	CcSEcCtD
Propofol—Asthenia—Cyclosporine—psoriasis	6.39e-05	0.000379	CcSEcCtD
Propofol—Pain—Triamcinolone—psoriasis	6.37e-05	0.000378	CcSEcCtD
Propofol—UGT1A9—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—PPARG—psoriasis	6.37e-05	0.00126	CbGpPWpGaD
Propofol—Loss of consciousness—Prednisone—psoriasis	6.34e-05	0.000376	CcSEcCtD
Propofol—CYP3A4—Biological oxidations—CYP2S1—psoriasis	6.33e-05	0.00125	CbGpPWpGaD
Propofol—Hypotension—Betamethasone—psoriasis	6.32e-05	0.000375	CcSEcCtD
Propofol—Hypotension—Dexamethasone—psoriasis	6.32e-05	0.000375	CcSEcCtD
Propofol—Pruritus—Cyclosporine—psoriasis	6.3e-05	0.000374	CcSEcCtD
Propofol—Urticaria—Hydrocortisone—psoriasis	6.29e-05	0.000373	CcSEcCtD
Propofol—GABRA1—SIDS Susceptibility Pathways—IL10—psoriasis	6.28e-05	0.00124	CbGpPWpGaD
Propofol—Body temperature increased—Hydrocortisone—psoriasis	6.26e-05	0.000371	CcSEcCtD
Propofol—Abdominal pain—Hydrocortisone—psoriasis	6.26e-05	0.000371	CcSEcCtD
Propofol—Convulsion—Prednisone—psoriasis	6.25e-05	0.000371	CcSEcCtD
Propofol—CYP3A4—Metapathway biotransformation—CYP2S1—psoriasis	6.24e-05	0.00123	CbGpPWpGaD
Propofol—Asthenia—Mycophenolate mofetil—psoriasis	6.23e-05	0.00037	CcSEcCtD
Propofol—Hypertension—Prednisone—psoriasis	6.23e-05	0.00037	CcSEcCtD
Propofol—Chills—Methotrexate—psoriasis	6.22e-05	0.000369	CcSEcCtD
Propofol—Musculoskeletal discomfort—Dexamethasone—psoriasis	6.16e-05	0.000366	CcSEcCtD
Propofol—Musculoskeletal discomfort—Betamethasone—psoriasis	6.16e-05	0.000366	CcSEcCtD
Propofol—CYP1A1—Aryl Hydrocarbon Receptor Pathway—IFNG—psoriasis	6.16e-05	0.00122	CbGpPWpGaD
Propofol—CYP2A6—Fluoropyrimidine Activity—TP53—psoriasis	6.15e-05	0.00122	CbGpPWpGaD
Propofol—Pruritus—Mycophenolate mofetil—psoriasis	6.15e-05	0.000365	CcSEcCtD
Propofol—Myalgia—Prednisone—psoriasis	6.14e-05	0.000365	CcSEcCtD
Propofol—Feeling abnormal—Triamcinolone—psoriasis	6.14e-05	0.000364	CcSEcCtD
Propofol—Anxiety—Prednisone—psoriasis	6.12e-05	0.000363	CcSEcCtD
Propofol—Insomnia—Betamethasone—psoriasis	6.12e-05	0.000363	CcSEcCtD
Propofol—Insomnia—Dexamethasone—psoriasis	6.12e-05	0.000363	CcSEcCtD
Propofol—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	6.1e-05	0.0012	CbGpPWpGaD
Propofol—Diarrhoea—Cyclosporine—psoriasis	6.09e-05	0.000362	CcSEcCtD
Propofol—Paraesthesia—Betamethasone—psoriasis	6.07e-05	0.00036	CcSEcCtD
Propofol—Paraesthesia—Dexamethasone—psoriasis	6.07e-05	0.00036	CcSEcCtD
Propofol—CYP2C19—Melatonin metabolism and effects—NFKB1—psoriasis	6.07e-05	0.0012	CbGpPWpGaD
Propofol—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—CARM1—psoriasis	6.05e-05	0.0012	CbGpPWpGaD
Propofol—Erythema—Methotrexate—psoriasis	6.03e-05	0.000358	CcSEcCtD
Propofol—ALB—Selenium Micronutrient Network—CAT—psoriasis	6.02e-05	0.00119	CbGpPWpGaD
Propofol—ALB—Folate Metabolism—CRP—psoriasis	6.01e-05	0.00119	CbGpPWpGaD
Propofol—GABRB3—BDNF signaling pathway—NFKBIA—psoriasis	5.98e-05	0.00118	CbGpPWpGaD
Propofol—Diarrhoea—Mycophenolate mofetil—psoriasis	5.95e-05	0.000353	CcSEcCtD
Propofol—Urticaria—Triamcinolone—psoriasis	5.92e-05	0.000351	CcSEcCtD
Propofol—Dysgeusia—Methotrexate—psoriasis	5.91e-05	0.00035	CcSEcCtD
Propofol—Body temperature increased—Triamcinolone—psoriasis	5.89e-05	0.00035	CcSEcCtD
Propofol—Dizziness—Cyclosporine—psoriasis	5.89e-05	0.00035	CcSEcCtD
Propofol—Oedema—Prednisone—psoriasis	5.89e-05	0.000349	CcSEcCtD
Propofol—Anaphylactic shock—Prednisone—psoriasis	5.89e-05	0.000349	CcSEcCtD
Propofol—Fatigue—Betamethasone—psoriasis	5.83e-05	0.000346	CcSEcCtD
Propofol—Fatigue—Dexamethasone—psoriasis	5.83e-05	0.000346	CcSEcCtD
Propofol—Shock—Prednisone—psoriasis	5.8e-05	0.000344	CcSEcCtD
Propofol—Pain—Betamethasone—psoriasis	5.78e-05	0.000343	CcSEcCtD
Propofol—Pain—Dexamethasone—psoriasis	5.78e-05	0.000343	CcSEcCtD
Propofol—UGT1A8—Metabolism—CARM1—psoriasis	5.78e-05	0.00114	CbGpPWpGaD
Propofol—Tachycardia—Prednisone—psoriasis	5.75e-05	0.000341	CcSEcCtD
Propofol—Dizziness—Mycophenolate mofetil—psoriasis	5.75e-05	0.000341	CcSEcCtD
Propofol—CYP2C18—Metabolism—NDUFA5—psoriasis	5.69e-05	0.00113	CbGpPWpGaD
Propofol—Hyperhidrosis—Prednisone—psoriasis	5.69e-05	0.000338	CcSEcCtD
Propofol—Asthenia—Hydrocortisone—psoriasis	5.68e-05	0.000337	CcSEcCtD
Propofol—Vomiting—Cyclosporine—psoriasis	5.66e-05	0.000336	CcSEcCtD
Propofol—Rash—Cyclosporine—psoriasis	5.62e-05	0.000333	CcSEcCtD
Propofol—Dermatitis—Cyclosporine—psoriasis	5.61e-05	0.000333	CcSEcCtD
Propofol—Pruritus—Hydrocortisone—psoriasis	5.6e-05	0.000332	CcSEcCtD
Propofol—Headache—Cyclosporine—psoriasis	5.58e-05	0.000331	CcSEcCtD
Propofol—CYP2D6—Melatonin metabolism and effects—NFKB1—psoriasis	5.58e-05	0.0011	CbGpPWpGaD
Propofol—Feeling abnormal—Dexamethasone—psoriasis	5.57e-05	0.000331	CcSEcCtD
Propofol—Feeling abnormal—Betamethasone—psoriasis	5.57e-05	0.000331	CcSEcCtD
Propofol—ALB—Folate Metabolism—ICAM1—psoriasis	5.53e-05	0.00109	CbGpPWpGaD
Propofol—Vomiting—Mycophenolate mofetil—psoriasis	5.53e-05	0.000328	CcSEcCtD
Propofol—Rash—Mycophenolate mofetil—psoriasis	5.48e-05	0.000325	CcSEcCtD
Propofol—Dermatitis—Mycophenolate mofetil—psoriasis	5.47e-05	0.000325	CcSEcCtD
Propofol—CYP3A4—Tryptophan metabolism—CAT—psoriasis	5.46e-05	0.00108	CbGpPWpGaD
Propofol—Headache—Mycophenolate mofetil—psoriasis	5.44e-05	0.000323	CcSEcCtD
Propofol—Diarrhoea—Hydrocortisone—psoriasis	5.42e-05	0.000321	CcSEcCtD
Propofol—Urticaria—Betamethasone—psoriasis	5.37e-05	0.000319	CcSEcCtD
Propofol—Urticaria—Dexamethasone—psoriasis	5.37e-05	0.000319	CcSEcCtD
Propofol—Musculoskeletal discomfort—Prednisone—psoriasis	5.37e-05	0.000318	CcSEcCtD
Propofol—Dizziness—Prednisolone—psoriasis	5.36e-05	0.000318	CcSEcCtD
Propofol—Asthenia—Triamcinolone—psoriasis	5.35e-05	0.000317	CcSEcCtD
Propofol—Abdominal pain—Betamethasone—psoriasis	5.35e-05	0.000317	CcSEcCtD
Propofol—Abdominal pain—Dexamethasone—psoriasis	5.35e-05	0.000317	CcSEcCtD
Propofol—Body temperature increased—Dexamethasone—psoriasis	5.35e-05	0.000317	CcSEcCtD
Propofol—Body temperature increased—Betamethasone—psoriasis	5.35e-05	0.000317	CcSEcCtD
Propofol—Insomnia—Prednisone—psoriasis	5.33e-05	0.000316	CcSEcCtD
Propofol—CYP1A1—Aryl Hydrocarbon Receptor Pathway—JUN—psoriasis	5.32e-05	0.00105	CbGpPWpGaD
Propofol—Nausea—Cyclosporine—psoriasis	5.29e-05	0.000314	CcSEcCtD
Propofol—Paraesthesia—Prednisone—psoriasis	5.29e-05	0.000314	CcSEcCtD
Propofol—Pruritus—Triamcinolone—psoriasis	5.27e-05	0.000313	CcSEcCtD
Propofol—Cough—Methotrexate—psoriasis	5.26e-05	0.000312	CcSEcCtD
Propofol—Dizziness—Hydrocortisone—psoriasis	5.24e-05	0.000311	CcSEcCtD
Propofol—Convulsion—Methotrexate—psoriasis	5.23e-05	0.00031	CcSEcCtD
Propofol—ALB—Vitamin B12 Metabolism—IFNG—psoriasis	5.17e-05	0.00102	CbGpPWpGaD
Propofol—Nausea—Mycophenolate mofetil—psoriasis	5.16e-05	0.000306	CcSEcCtD
Propofol—Myalgia—Methotrexate—psoriasis	5.14e-05	0.000305	CcSEcCtD
Propofol—Chest pain—Methotrexate—psoriasis	5.14e-05	0.000305	CcSEcCtD
Propofol—CYP1A1—Aryl Hydrocarbon Receptor—NFKB1—psoriasis	5.12e-05	0.00101	CbGpPWpGaD
Propofol—Rash—Prednisolone—psoriasis	5.11e-05	0.000303	CcSEcCtD
Propofol—Dermatitis—Prednisolone—psoriasis	5.11e-05	0.000303	CcSEcCtD
Propofol—Fatigue—Prednisone—psoriasis	5.08e-05	0.000301	CcSEcCtD
Propofol—Headache—Prednisolone—psoriasis	5.08e-05	0.000301	CcSEcCtD
Propofol—Vomiting—Hydrocortisone—psoriasis	5.03e-05	0.000299	CcSEcCtD
Propofol—Rash—Hydrocortisone—psoriasis	4.99e-05	0.000296	CcSEcCtD
Propofol—Dermatitis—Hydrocortisone—psoriasis	4.99e-05	0.000296	CcSEcCtD
Propofol—Confusional state—Methotrexate—psoriasis	4.96e-05	0.000295	CcSEcCtD
Propofol—Headache—Hydrocortisone—psoriasis	4.96e-05	0.000294	CcSEcCtD
Propofol—Dizziness—Triamcinolone—psoriasis	4.93e-05	0.000292	CcSEcCtD
Propofol—Anaphylactic shock—Methotrexate—psoriasis	4.92e-05	0.000292	CcSEcCtD
Propofol—SCN2A—Axon guidance—TYK2—psoriasis	4.92e-05	0.000972	CbGpPWpGaD
Propofol—SCN4A—Axon guidance—TYK2—psoriasis	4.92e-05	0.000972	CbGpPWpGaD
Propofol—Feeling abnormal—Prednisone—psoriasis	4.85e-05	0.000288	CcSEcCtD
Propofol—Asthenia—Dexamethasone—psoriasis	4.85e-05	0.000288	CcSEcCtD
Propofol—Asthenia—Betamethasone—psoriasis	4.85e-05	0.000288	CcSEcCtD
Propofol—CYP2C18—Metabolism—CYP2S1—psoriasis	4.84e-05	0.000957	CbGpPWpGaD
Propofol—Nausea—Prednisolone—psoriasis	4.81e-05	0.000286	CcSEcCtD
Propofol—GABRB2—Transmembrane transport of small molecules—CP—psoriasis	4.79e-05	0.000946	CbGpPWpGaD
Propofol—Pruritus—Betamethasone—psoriasis	4.79e-05	0.000284	CcSEcCtD
Propofol—Pruritus—Dexamethasone—psoriasis	4.79e-05	0.000284	CcSEcCtD
Propofol—ALB—Selenium Micronutrient Network—CRP—psoriasis	4.78e-05	0.000944	CbGpPWpGaD
Propofol—Hyperhidrosis—Methotrexate—psoriasis	4.76e-05	0.000282	CcSEcCtD
Propofol—Vomiting—Triamcinolone—psoriasis	4.74e-05	0.000281	CcSEcCtD
Propofol—CYP1A2—Melatonin metabolism and effects—NFKB1—psoriasis	4.73e-05	0.000934	CbGpPWpGaD
Propofol—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	4.7e-05	0.000929	CbGpPWpGaD
Propofol—Nausea—Hydrocortisone—psoriasis	4.7e-05	0.000279	CcSEcCtD
Propofol—Rash—Triamcinolone—psoriasis	4.7e-05	0.000279	CcSEcCtD
Propofol—Dermatitis—Triamcinolone—psoriasis	4.7e-05	0.000279	CcSEcCtD
Propofol—Urticaria—Prednisone—psoriasis	4.68e-05	0.000278	CcSEcCtD
Propofol—Headache—Triamcinolone—psoriasis	4.67e-05	0.000277	CcSEcCtD
Propofol—Abdominal pain—Prednisone—psoriasis	4.66e-05	0.000276	CcSEcCtD
Propofol—Body temperature increased—Prednisone—psoriasis	4.66e-05	0.000276	CcSEcCtD
Propofol—CYP1A1—Aryl Hydrocarbon Receptor—VEGFA—psoriasis	4.65e-05	0.000919	CbGpPWpGaD
Propofol—Diarrhoea—Betamethasone—psoriasis	4.63e-05	0.000275	CcSEcCtD
Propofol—Diarrhoea—Dexamethasone—psoriasis	4.63e-05	0.000275	CcSEcCtD
Propofol—Hypotension—Methotrexate—psoriasis	4.6e-05	0.000273	CcSEcCtD
Propofol—SCN4A—Developmental Biology—LEP—psoriasis	4.6e-05	0.000909	CbGpPWpGaD
Propofol—SCN2A—Developmental Biology—LEP—psoriasis	4.6e-05	0.000909	CbGpPWpGaD
Propofol—GABRB2—Transmembrane transport of small molecules—CARM1—psoriasis	4.57e-05	0.000902	CbGpPWpGaD
Propofol—UGT1A1—Metabolism—NDUFA5—psoriasis	4.5e-05	0.000889	CbGpPWpGaD
Propofol—UGT1A9—Metabolism—NDUFA5—psoriasis	4.5e-05	0.000889	CbGpPWpGaD
Propofol—GABRA2—Transmembrane transport of small molecules—CP—psoriasis	4.49e-05	0.000887	CbGpPWpGaD
Propofol—Musculoskeletal discomfort—Methotrexate—psoriasis	4.48e-05	0.000266	CcSEcCtD
Propofol—Dizziness—Betamethasone—psoriasis	4.47e-05	0.000265	CcSEcCtD
Propofol—Dizziness—Dexamethasone—psoriasis	4.47e-05	0.000265	CcSEcCtD
Propofol—GABRB3—Transmembrane transport of small molecules—CP—psoriasis	4.46e-05	0.000881	CbGpPWpGaD
Propofol—Insomnia—Methotrexate—psoriasis	4.45e-05	0.000264	CcSEcCtD
Propofol—Nausea—Triamcinolone—psoriasis	4.43e-05	0.000263	CcSEcCtD
Propofol—Paraesthesia—Methotrexate—psoriasis	4.42e-05	0.000262	CcSEcCtD
Propofol—ALB—Selenium Micronutrient Network—ICAM1—psoriasis	4.39e-05	0.000868	CbGpPWpGaD
Propofol—Dyspnoea—Methotrexate—psoriasis	4.39e-05	0.00026	CcSEcCtD
Propofol—UGT1A9—Fatty acid, triacylglycerol, and ketone body metabolism—PPARG—psoriasis	4.39e-05	0.000867	CbGpPWpGaD
Propofol—GABRG2—Transmembrane transport of small molecules—CP—psoriasis	4.38e-05	0.000865	CbGpPWpGaD
Propofol—Somnolence—Methotrexate—psoriasis	4.38e-05	0.00026	CcSEcCtD
Propofol—ALB—SLC-mediated transmembrane transport—CP—psoriasis	4.31e-05	0.000852	CbGpPWpGaD
Propofol—ALB—Vitamin B12 Metabolism—NFKB1—psoriasis	4.3e-05	0.00085	CbGpPWpGaD
Propofol—Vomiting—Betamethasone—psoriasis	4.3e-05	0.000255	CcSEcCtD
Propofol—Vomiting—Dexamethasone—psoriasis	4.3e-05	0.000255	CcSEcCtD
Propofol—GABRA2—Transmembrane transport of small molecules—CARM1—psoriasis	4.28e-05	0.000846	CbGpPWpGaD
Propofol—Rash—Dexamethasone—psoriasis	4.26e-05	0.000253	CcSEcCtD
Propofol—Rash—Betamethasone—psoriasis	4.26e-05	0.000253	CcSEcCtD
Propofol—Dermatitis—Betamethasone—psoriasis	4.26e-05	0.000253	CcSEcCtD
Propofol—Dermatitis—Dexamethasone—psoriasis	4.26e-05	0.000253	CcSEcCtD
Propofol—GABRB3—Transmembrane transport of small molecules—CARM1—psoriasis	4.25e-05	0.00084	CbGpPWpGaD
Propofol—Fatigue—Methotrexate—psoriasis	4.24e-05	0.000252	CcSEcCtD
Propofol—Headache—Betamethasone—psoriasis	4.24e-05	0.000251	CcSEcCtD
Propofol—Headache—Dexamethasone—psoriasis	4.24e-05	0.000251	CcSEcCtD
Propofol—Asthenia—Prednisone—psoriasis	4.23e-05	0.000251	CcSEcCtD
Propofol—UGT1A6—Metabolism—CARM1—psoriasis	4.22e-05	0.000833	CbGpPWpGaD
Propofol—Pain—Methotrexate—psoriasis	4.21e-05	0.00025	CcSEcCtD
Propofol—ALB—Folate Metabolism—IFNG—psoriasis	4.21e-05	0.000831	CbGpPWpGaD
Propofol—CYP1B1—Metabolism—NDUFA5—psoriasis	4.2e-05	0.000829	CbGpPWpGaD
Propofol—UGT1A9—Metabolism of lipids and lipoproteins—CARM1—psoriasis	4.2e-05	0.000829	CbGpPWpGaD
Propofol—GABRG2—Transmembrane transport of small molecules—CARM1—psoriasis	4.18e-05	0.000825	CbGpPWpGaD
Propofol—Pruritus—Prednisone—psoriasis	4.17e-05	0.000247	CcSEcCtD
Propofol—Feeling abnormal—Methotrexate—psoriasis	4.06e-05	0.000241	CcSEcCtD
Propofol—Diarrhoea—Prednisone—psoriasis	4.03e-05	0.000239	CcSEcCtD
Propofol—Nausea—Dexamethasone—psoriasis	4.02e-05	0.000238	CcSEcCtD
Propofol—Nausea—Betamethasone—psoriasis	4.02e-05	0.000238	CcSEcCtD
Propofol—SCN2A—Developmental Biology—PPARG—psoriasis	4.01e-05	0.000791	CbGpPWpGaD
Propofol—SCN4A—Developmental Biology—PPARG—psoriasis	4.01e-05	0.000791	CbGpPWpGaD
Propofol—CYP1A1—Aryl Hydrocarbon Receptor—TNF—psoriasis	3.99e-05	0.000788	CbGpPWpGaD
Propofol—CYP1A1—Aryl Hydrocarbon Receptor Pathway—TNF—psoriasis	3.99e-05	0.000788	CbGpPWpGaD
Propofol—GABRB3—BDNF signaling pathway—JUN—psoriasis	3.96e-05	0.000783	CbGpPWpGaD
Propofol—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IFNG—psoriasis	3.93e-05	0.000776	CbGpPWpGaD
Propofol—CYP1B1—Metabolism of lipids and lipoproteins—CARM1—psoriasis	3.91e-05	0.000773	CbGpPWpGaD
Propofol—Urticaria—Methotrexate—psoriasis	3.91e-05	0.000232	CcSEcCtD
Propofol—Dizziness—Prednisone—psoriasis	3.9e-05	0.000231	CcSEcCtD
Propofol—Body temperature increased—Methotrexate—psoriasis	3.89e-05	0.000231	CcSEcCtD
Propofol—Abdominal pain—Methotrexate—psoriasis	3.89e-05	0.000231	CcSEcCtD
Propofol—UGT1A1—Metabolism—CYP2S1—psoriasis	3.83e-05	0.000756	CbGpPWpGaD
Propofol—UGT1A9—Metabolism—CYP2S1—psoriasis	3.83e-05	0.000756	CbGpPWpGaD
Propofol—GABRA1—Transmembrane transport of small molecules—CP—psoriasis	3.83e-05	0.000756	CbGpPWpGaD
Propofol—GABRB3—BDNF signaling pathway—NFKB1—psoriasis	3.82e-05	0.000754	CbGpPWpGaD
Propofol—Vomiting—Prednisone—psoriasis	3.75e-05	0.000222	CcSEcCtD
Propofol—CYP1A1—PPARA activates gene expression—PPARG—psoriasis	3.74e-05	0.000738	CbGpPWpGaD
Propofol—Rash—Prednisone—psoriasis	3.71e-05	0.00022	CcSEcCtD
Propofol—Dermatitis—Prednisone—psoriasis	3.71e-05	0.00022	CcSEcCtD
Propofol—Headache—Prednisone—psoriasis	3.69e-05	0.000219	CcSEcCtD
Propofol—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—PPARG—psoriasis	3.66e-05	0.000723	CbGpPWpGaD
Propofol—GABRA1—Transmembrane transport of small molecules—CARM1—psoriasis	3.65e-05	0.000721	CbGpPWpGaD
Propofol—CYP1B1—Metabolism—CYP2S1—psoriasis	3.57e-05	0.000705	CbGpPWpGaD
Propofol—UGT1A8—Metabolism—CAT—psoriasis	3.55e-05	0.000702	CbGpPWpGaD
Propofol—Asthenia—Methotrexate—psoriasis	3.53e-05	0.00021	CcSEcCtD
Propofol—SCN2A—Developmental Biology—TYK2—psoriasis	3.51e-05	0.000694	CbGpPWpGaD
Propofol—SCN4A—Developmental Biology—TYK2—psoriasis	3.51e-05	0.000694	CbGpPWpGaD
Propofol—ALB—Folate Metabolism—NFKB1—psoriasis	3.5e-05	0.000691	CbGpPWpGaD
Propofol—Nausea—Prednisone—psoriasis	3.5e-05	0.000208	CcSEcCtD
Propofol—Pruritus—Methotrexate—psoriasis	3.48e-05	0.000207	CcSEcCtD
Propofol—SCN4A—Axon guidance—VEGFA—psoriasis	3.48e-05	0.000687	CbGpPWpGaD
Propofol—SCN2A—Axon guidance—VEGFA—psoriasis	3.48e-05	0.000687	CbGpPWpGaD
Propofol—CYP2A6—Metabolism—NDUFA5—psoriasis	3.47e-05	0.000686	CbGpPWpGaD
Propofol—GABRA1—SIDS Susceptibility Pathways—CXCL8—psoriasis	3.43e-05	0.000678	CbGpPWpGaD
Propofol—GABRB3—BDNF signaling pathway—STAT3—psoriasis	3.43e-05	0.000677	CbGpPWpGaD
Propofol—CYP1A2—Aryl Hydrocarbon Receptor Pathway—JUN—psoriasis	3.39e-05	0.000671	CbGpPWpGaD
Propofol—Diarrhoea—Methotrexate—psoriasis	3.37e-05	0.0002	CcSEcCtD
Propofol—ALB—Vitamin B12 Metabolism—TNF—psoriasis	3.35e-05	0.000661	CbGpPWpGaD
Propofol—ALB—Selenium Micronutrient Network—IFNG—psoriasis	3.34e-05	0.00066	CbGpPWpGaD
Propofol—CYP1A2—Aryl Hydrocarbon Receptor—NFKB1—psoriasis	3.27e-05	0.000646	CbGpPWpGaD
Propofol—Dizziness—Methotrexate—psoriasis	3.26e-05	0.000193	CcSEcCtD
Propofol—GABRA1—SIDS Susceptibility Pathways—JUN—psoriasis	3.19e-05	0.000631	CbGpPWpGaD
Propofol—Vomiting—Methotrexate—psoriasis	3.13e-05	0.000186	CcSEcCtD
Propofol—Rash—Methotrexate—psoriasis	3.1e-05	0.000184	CcSEcCtD
Propofol—Dermatitis—Methotrexate—psoriasis	3.1e-05	0.000184	CcSEcCtD
Propofol—Headache—Methotrexate—psoriasis	3.08e-05	0.000183	CcSEcCtD
Propofol—GABRA1—SIDS Susceptibility Pathways—NFKB1—psoriasis	3.07e-05	0.000607	CbGpPWpGaD
Propofol—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—psoriasis	2.97e-05	0.000586	CbGpPWpGaD
Propofol—CYP2A6—Metabolism—CYP2S1—psoriasis	2.95e-05	0.000583	CbGpPWpGaD
Propofol—Nausea—Methotrexate—psoriasis	2.92e-05	0.000173	CcSEcCtD
Propofol—CYP2B6—Metabolism—NDUFA5—psoriasis	2.8e-05	0.000553	CbGpPWpGaD
Propofol—GABRA1—SIDS Susceptibility Pathways—VEGFA—psoriasis	2.79e-05	0.000551	CbGpPWpGaD
Propofol—ALB—Selenium Micronutrient Network—NFKB1—psoriasis	2.78e-05	0.000549	CbGpPWpGaD
Propofol—UGT1A8—Metabolism—APOE—psoriasis	2.76e-05	0.000546	CbGpPWpGaD
Propofol—CYP2E1—Metabolism—NDUFA5—psoriasis	2.74e-05	0.000542	CbGpPWpGaD
Propofol—SCN2A—Developmental Biology—NFKB1—psoriasis	2.74e-05	0.00054	CbGpPWpGaD
Propofol—SCN4A—Developmental Biology—NFKB1—psoriasis	2.74e-05	0.00054	CbGpPWpGaD
Propofol—ALB—Platelet degranulation—VEGFA—psoriasis	2.72e-05	0.000538	CbGpPWpGaD
Propofol—ALB—Folate Metabolism—TNF—psoriasis	2.72e-05	0.000538	CbGpPWpGaD
Propofol—ALB—Vitamin B12 Metabolism—IL6—psoriasis	2.7e-05	0.000533	CbGpPWpGaD
Propofol—ALB—Hemostasis—ITGAL—psoriasis	2.62e-05	0.000518	CbGpPWpGaD
Propofol—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—psoriasis	2.59e-05	0.000513	CbGpPWpGaD
Propofol—UGT1A6—Metabolism—CAT—psoriasis	2.59e-05	0.000512	CbGpPWpGaD
Propofol—CYP1A1—Metabolism—NDUFA5—psoriasis	2.59e-05	0.000511	CbGpPWpGaD
Propofol—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—psoriasis	2.54e-05	0.000502	CbGpPWpGaD
Propofol—CYP1A2—Aryl Hydrocarbon Receptor—TNF—psoriasis	2.54e-05	0.000502	CbGpPWpGaD
Propofol—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—PPARG—psoriasis	2.52e-05	0.000498	CbGpPWpGaD
Propofol—SCN2A—Developmental Biology—VEGFA—psoriasis	2.48e-05	0.00049	CbGpPWpGaD
Propofol—SCN4A—Developmental Biology—VEGFA—psoriasis	2.48e-05	0.00049	CbGpPWpGaD
Propofol—SCN2A—Developmental Biology—STAT3—psoriasis	2.46e-05	0.000486	CbGpPWpGaD
Propofol—SCN4A—Developmental Biology—STAT3—psoriasis	2.46e-05	0.000486	CbGpPWpGaD
Propofol—CYP1A1—Metabolism of lipids and lipoproteins—CARM1—psoriasis	2.41e-05	0.000476	CbGpPWpGaD
Propofol—SCN2A—Axon guidance—IL6—psoriasis	2.41e-05	0.000475	CbGpPWpGaD
Propofol—SCN4A—Axon guidance—IL6—psoriasis	2.41e-05	0.000475	CbGpPWpGaD
Propofol—UGT1A8—Metabolism—PPARG—psoriasis	2.41e-05	0.000475	CbGpPWpGaD
Propofol—ALB—Folate Metabolism—TP53—psoriasis	2.4e-05	0.000474	CbGpPWpGaD
Propofol—GABRA1—SIDS Susceptibility Pathways—TNF—psoriasis	2.39e-05	0.000472	CbGpPWpGaD
Propofol—CYP2B6—Metabolism—CYP2S1—psoriasis	2.38e-05	0.00047	CbGpPWpGaD
Propofol—CYP2C8—Metabolism—NDUFA5—psoriasis	2.37e-05	0.000468	CbGpPWpGaD
Propofol—CYP2C18—Metabolism—CARM1—psoriasis	2.36e-05	0.000467	CbGpPWpGaD
Propofol—ALB—Metabolism—NDUFA5—psoriasis	2.36e-05	0.000466	CbGpPWpGaD
Propofol—CYP2E1—Metabolism—CYP2S1—psoriasis	2.33e-05	0.000461	CbGpPWpGaD
Propofol—CYP2C8—Metabolism of lipids and lipoproteins—CARM1—psoriasis	2.21e-05	0.000437	CbGpPWpGaD
Propofol—CYP1A1—Metabolism—CYP2S1—psoriasis	2.2e-05	0.000434	CbGpPWpGaD
Propofol—ALB—Metabolism of lipids and lipoproteins—CARM1—psoriasis	2.2e-05	0.000434	CbGpPWpGaD
Propofol—ALB—Folate Metabolism—IL6—psoriasis	2.2e-05	0.000434	CbGpPWpGaD
Propofol—ALB—Transmembrane transport of small molecules—CP—psoriasis	2.19e-05	0.000433	CbGpPWpGaD
Propofol—ALB—Selenium Micronutrient Network—TNF—psoriasis	2.16e-05	0.000427	CbGpPWpGaD
Propofol—SCN4A—Developmental Biology—TNF—psoriasis	2.13e-05	0.00042	CbGpPWpGaD
Propofol—SCN2A—Developmental Biology—TNF—psoriasis	2.13e-05	0.00042	CbGpPWpGaD
Propofol—CYP2C19—Metabolism—NDUFA5—psoriasis	2.12e-05	0.000418	CbGpPWpGaD
Propofol—ALB—Transmembrane transport of small molecules—CARM1—psoriasis	2.09e-05	0.000413	CbGpPWpGaD
Propofol—CYP2C8—Metabolism—CYP2S1—psoriasis	2.02e-05	0.000398	CbGpPWpGaD
Propofol—UGT1A6—Metabolism—APOE—psoriasis	2.01e-05	0.000398	CbGpPWpGaD
Propofol—UGT1A9—Metabolism of lipids and lipoproteins—APOE—psoriasis	2.01e-05	0.000396	CbGpPWpGaD
Propofol—ALB—Metabolism—CYP2S1—psoriasis	2e-05	0.000396	CbGpPWpGaD
Propofol—CYP2C19—Metabolism of lipids and lipoproteins—CARM1—psoriasis	1.97e-05	0.00039	CbGpPWpGaD
Propofol—CYP2D6—Metabolism—NDUFA5—psoriasis	1.95e-05	0.000384	CbGpPWpGaD
Propofol—CYP2C9—Metabolism—NDUFA5—psoriasis	1.93e-05	0.000381	CbGpPWpGaD
Propofol—GABRA1—SIDS Susceptibility Pathways—IL6—psoriasis	1.93e-05	0.000381	CbGpPWpGaD
Propofol—CYP1B1—Metabolism of lipids and lipoproteins—APOE—psoriasis	1.87e-05	0.00037	CbGpPWpGaD
Propofol—UGT1A1—Metabolism—CARM1—psoriasis	1.87e-05	0.000369	CbGpPWpGaD
Propofol—UGT1A9—Metabolism—CARM1—psoriasis	1.87e-05	0.000369	CbGpPWpGaD
Propofol—CYP2C19—Metabolism—CYP2S1—psoriasis	1.8e-05	0.000355	CbGpPWpGaD
Propofol—CYP2C9—Metabolism of lipids and lipoproteins—CARM1—psoriasis	1.8e-05	0.000355	CbGpPWpGaD
Propofol—UGT1A6—Metabolism—PPARG—psoriasis	1.75e-05	0.000347	CbGpPWpGaD
Propofol—UGT1A9—Metabolism of lipids and lipoproteins—PPARG—psoriasis	1.75e-05	0.000345	CbGpPWpGaD
Propofol—ALB—Selenium Micronutrient Network—IL6—psoriasis	1.75e-05	0.000345	CbGpPWpGaD
Propofol—CYP1B1—Metabolism—CARM1—psoriasis	1.74e-05	0.000344	CbGpPWpGaD
Propofol—SCN4A—Developmental Biology—IL6—psoriasis	1.72e-05	0.000339	CbGpPWpGaD
Propofol—SCN2A—Developmental Biology—IL6—psoriasis	1.72e-05	0.000339	CbGpPWpGaD
Propofol—CYP2D6—Metabolism—CYP2S1—psoriasis	1.65e-05	0.000327	CbGpPWpGaD
Propofol—CYP1A2—Metabolism—NDUFA5—psoriasis	1.65e-05	0.000326	CbGpPWpGaD
Propofol—CYP2C9—Metabolism—CYP2S1—psoriasis	1.64e-05	0.000324	CbGpPWpGaD
Propofol—CYP1B1—Metabolism of lipids and lipoproteins—PPARG—psoriasis	1.63e-05	0.000322	CbGpPWpGaD
Propofol—CYP1A2—Metabolism of lipids and lipoproteins—CARM1—psoriasis	1.54e-05	0.000304	CbGpPWpGaD
Propofol—CYP2C18—Metabolism—CAT—psoriasis	1.45e-05	0.000287	CbGpPWpGaD
Propofol—CYP2A6—Metabolism—CARM1—psoriasis	1.44e-05	0.000285	CbGpPWpGaD
Propofol—CYP1A2—Metabolism—CYP2S1—psoriasis	1.4e-05	0.000277	CbGpPWpGaD
Propofol—CYP3A4—Metabolism—NDUFA5—psoriasis	1.27e-05	0.000251	CbGpPWpGaD
Propofol—ALB—Platelet activation, signaling and aggregation—VEGFA—psoriasis	1.21e-05	0.000239	CbGpPWpGaD
Propofol—CYP2B6—Metabolism—CARM1—psoriasis	1.16e-05	0.00023	CbGpPWpGaD
Propofol—CYP1A1—Metabolism of lipids and lipoproteins—APOE—psoriasis	1.15e-05	0.000228	CbGpPWpGaD
Propofol—UGT1A1—Metabolism—CAT—psoriasis	1.15e-05	0.000227	CbGpPWpGaD
Propofol—UGT1A9—Metabolism—CAT—psoriasis	1.15e-05	0.000227	CbGpPWpGaD
Propofol—CYP2E1—Metabolism—CARM1—psoriasis	1.14e-05	0.000225	CbGpPWpGaD
Propofol—CYP2C18—Metabolism—APOE—psoriasis	1.13e-05	0.000223	CbGpPWpGaD
Propofol—CYP3A4—Metabolism—CYP2S1—psoriasis	1.08e-05	0.000214	CbGpPWpGaD
Propofol—ALB—Hemostasis—NOS2—psoriasis	1.07e-05	0.000212	CbGpPWpGaD
Propofol—CYP1A1—Metabolism—CARM1—psoriasis	1.07e-05	0.000212	CbGpPWpGaD
Propofol—CYP1B1—Metabolism—CAT—psoriasis	1.07e-05	0.000212	CbGpPWpGaD
Propofol—CYP2C8—Metabolism of lipids and lipoproteins—APOE—psoriasis	1.06e-05	0.000209	CbGpPWpGaD
Propofol—ALB—Metabolism of lipids and lipoproteins—APOE—psoriasis	1.05e-05	0.000207	CbGpPWpGaD
Propofol—CYP1A1—Metabolism of lipids and lipoproteins—PPARG—psoriasis	1e-05	0.000198	CbGpPWpGaD
Propofol—CYP2C18—Metabolism—PPARG—psoriasis	9.84e-06	0.000194	CbGpPWpGaD
Propofol—CYP2C8—Metabolism—CARM1—psoriasis	9.84e-06	0.000194	CbGpPWpGaD
Propofol—ALB—Metabolism—CARM1—psoriasis	9.79e-06	0.000193	CbGpPWpGaD
Propofol—CYP2C19—Metabolism of lipids and lipoproteins—APOE—psoriasis	9.43e-06	0.000186	CbGpPWpGaD
Propofol—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—psoriasis	9.2e-06	0.000182	CbGpPWpGaD
Propofol—ALB—Metabolism of lipids and lipoproteins—PPARG—psoriasis	9.15e-06	0.000181	CbGpPWpGaD
Propofol—UGT1A1—Metabolism—APOE—psoriasis	8.93e-06	0.000176	CbGpPWpGaD
Propofol—UGT1A9—Metabolism—APOE—psoriasis	8.93e-06	0.000176	CbGpPWpGaD
Propofol—CYP2A6—Metabolism—CAT—psoriasis	8.86e-06	0.000175	CbGpPWpGaD
Propofol—CYP2C19—Metabolism—CARM1—psoriasis	8.79e-06	0.000174	CbGpPWpGaD
Propofol—CYP2C9—Metabolism of lipids and lipoproteins—APOE—psoriasis	8.6e-06	0.00017	CbGpPWpGaD
Propofol—CYP1B1—Metabolism—APOE—psoriasis	8.33e-06	0.000165	CbGpPWpGaD
Propofol—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—psoriasis	8.21e-06	0.000162	CbGpPWpGaD
Propofol—CYP2D6—Metabolism—CARM1—psoriasis	8.08e-06	0.00016	CbGpPWpGaD
Propofol—CYP2C9—Metabolism—CARM1—psoriasis	8.01e-06	0.000158	CbGpPWpGaD
Propofol—UGT1A9—Metabolism—PPARG—psoriasis	7.78e-06	0.000154	CbGpPWpGaD
Propofol—UGT1A1—Metabolism—PPARG—psoriasis	7.78e-06	0.000154	CbGpPWpGaD
Propofol—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—psoriasis	7.49e-06	0.000148	CbGpPWpGaD
Propofol—CYP1A2—Metabolism of lipids and lipoproteins—APOE—psoriasis	7.35e-06	0.000145	CbGpPWpGaD
Propofol—CYP1B1—Metabolism—PPARG—psoriasis	7.26e-06	0.000143	CbGpPWpGaD
Propofol—CYP2B6—Metabolism—CAT—psoriasis	7.15e-06	0.000141	CbGpPWpGaD
Propofol—CYP2E1—Metabolism—CAT—psoriasis	7e-06	0.000138	CbGpPWpGaD
Propofol—CYP2A6—Metabolism—APOE—psoriasis	6.89e-06	0.000136	CbGpPWpGaD
Propofol—CYP1A2—Metabolism—CARM1—psoriasis	6.85e-06	0.000135	CbGpPWpGaD
Propofol—CYP1A1—Metabolism—CAT—psoriasis	6.6e-06	0.00013	CbGpPWpGaD
Propofol—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—psoriasis	6.4e-06	0.000126	CbGpPWpGaD
Propofol—ALB—Hemostasis—VEGFA—psoriasis	6.23e-06	0.000123	CbGpPWpGaD
Propofol—CYP2C8—Metabolism—CAT—psoriasis	6.05e-06	0.00012	CbGpPWpGaD
Propofol—ALB—Metabolism—CAT—psoriasis	6.02e-06	0.000119	CbGpPWpGaD
Propofol—CYP2A6—Metabolism—PPARG—psoriasis	6e-06	0.000119	CbGpPWpGaD
Propofol—CYP2B6—Metabolism—APOE—psoriasis	5.56e-06	0.00011	CbGpPWpGaD
Propofol—CYP2E1—Metabolism—APOE—psoriasis	5.44e-06	0.000108	CbGpPWpGaD
Propofol—CYP2C19—Metabolism—CAT—psoriasis	5.4e-06	0.000107	CbGpPWpGaD
Propofol—CYP3A4—Metabolism—CARM1—psoriasis	5.28e-06	0.000104	CbGpPWpGaD
Propofol—CYP1A1—Metabolism—APOE—psoriasis	5.13e-06	0.000101	CbGpPWpGaD
Propofol—CYP2D6—Metabolism—CAT—psoriasis	4.97e-06	9.82e-05	CbGpPWpGaD
Propofol—CYP2C9—Metabolism—CAT—psoriasis	4.93e-06	9.73e-05	CbGpPWpGaD
Propofol—CYP2B6—Metabolism—PPARG—psoriasis	4.84e-06	9.56e-05	CbGpPWpGaD
Propofol—CYP2E1—Metabolism—PPARG—psoriasis	4.74e-06	9.37e-05	CbGpPWpGaD
Propofol—ALB—Hemostasis—TP53—psoriasis	4.7e-06	9.29e-05	CbGpPWpGaD
Propofol—CYP2C8—Metabolism—APOE—psoriasis	4.7e-06	9.29e-05	CbGpPWpGaD
Propofol—ALB—Metabolism—APOE—psoriasis	4.68e-06	9.24e-05	CbGpPWpGaD
Propofol—CYP1A1—Metabolism—PPARG—psoriasis	4.47e-06	8.83e-05	CbGpPWpGaD
Propofol—CYP1A2—Metabolism—CAT—psoriasis	4.21e-06	8.32e-05	CbGpPWpGaD
Propofol—CYP2C19—Metabolism—APOE—psoriasis	4.2e-06	8.3e-05	CbGpPWpGaD
Propofol—CYP2C8—Metabolism—PPARG—psoriasis	4.1e-06	8.09e-05	CbGpPWpGaD
Propofol—ALB—Metabolism—PPARG—psoriasis	4.07e-06	8.05e-05	CbGpPWpGaD
Propofol—CYP2D6—Metabolism—APOE—psoriasis	3.86e-06	7.63e-05	CbGpPWpGaD
Propofol—CYP2C9—Metabolism—APOE—psoriasis	3.83e-06	7.56e-05	CbGpPWpGaD
Propofol—CYP2C19—Metabolism—PPARG—psoriasis	3.66e-06	7.23e-05	CbGpPWpGaD
Propofol—CYP2D6—Metabolism—PPARG—psoriasis	3.36e-06	6.65e-05	CbGpPWpGaD
Propofol—CYP2C9—Metabolism—PPARG—psoriasis	3.33e-06	6.59e-05	CbGpPWpGaD
Propofol—CYP1A2—Metabolism—APOE—psoriasis	3.27e-06	6.46e-05	CbGpPWpGaD
Propofol—CYP3A4—Metabolism—CAT—psoriasis	3.25e-06	6.42e-05	CbGpPWpGaD
Propofol—CYP1A2—Metabolism—PPARG—psoriasis	2.85e-06	5.63e-05	CbGpPWpGaD
Propofol—CYP3A4—Metabolism—APOE—psoriasis	2.52e-06	4.99e-05	CbGpPWpGaD
Propofol—CYP3A4—Metabolism—PPARG—psoriasis	2.2e-06	4.34e-05	CbGpPWpGaD
